In May 2025, several Executive Orders were signed addressing diverse issues such as religious liberty, defunding biased media ...

Ron Lanton, Partner, Lanton Law, weighs in on the potential international trade, pricing, and access implications of tying US drug costs to those in other developed countries under the Most Favored ...

(Reuters) -Pfizer and other drug companies have met with the Trump administration to discuss most-favored-nation pricing but ...

President Donald Trump’s proposal to peg American drug costs to prices paid in other countries risks upending Medicaid’s drug ...

While many often say the pharmaceutical industry has the most powerful lobby, the truth is many politicians have grown ...

President Donald J. Trump just released his second executive order (EO) addressing high prescription drug prices. This is ...

President Trump recently issued an executive order, aiming to lower prescription costs down for Americans by aligning prices ...

Drug pricing has been under increased scrutiny under both the Trump and Biden administrations, including changes to cap ...

America's pharmaceutical sector is facing huge uncertainty from the tariff threat, cuts at the US Department of Health, and a ...

In the shadow of President Trump's efforts to lower drug prices, the Medicare drug price negotiation process that began in ...

Most-favored-nation pricing is “founded on incorrect assumptions about where high out-of-pocket costs really come from and what it would mean for the US to adopt cost-effectiveness standards used by ...

Amgen Q1 2025 results beat estimates with strong product growth. Stay updated on tariff risks and drug pricing impacts.